Novel pharmacotherapies for cocaine abuse - 1995 to present

Bibliography

• JOHNSON DN, VOCCI FJ: Medications development atthe National Institute on Drug Abuse: focus on cocaine. In: Cocaine Treatment: Research and Clinical Perspectives. NIDA Research Monograph Series, No. 135, US Dept. of Health and Human Services, NIH Publication No. 93–3639 (1993) 57–70.
   Google Scholar
• INSTITUTE OF MEDICINE: Pathways of addiction: opportu-nities in drug abuse research. National Academy Press (1996).
   Google Scholar
• JOHANSON CE, FISCHMAN MW: The pharmacology ofcocaine related to its abuse. Pharmacol. Rev. (1989) 41:3–52.
   PubMed Web of Science ®Google Scholar
• KELLEHER RT, MORSE WH: Determinants of the specific-ity of the behavioral effects of drugs. Ergebnisse der Physiologie, Biologie Chemie und Experimentellum Phar-makologie (1968) 60:1–56.
   PubMedGoogle Scholar
• MELLO NK, NEGUS SS: Preclinical evaluation of pharma-cotherapies for treatment of cocaine and opioid abuse using self-administration procedures. Neuropsychophar-macology (1996) 14:375-424. Maintains that selective effects of drugs on drug-reinforcedbehaviour is an effective preclinical screen for medications for drug abuse.
   Google Scholar
• WITKIN J: Pharmacotherapy of cocaine abuse: preclini-cal development. Neurosci. Biobehav. Rev. (1994) 18:121–142.
   PubMed Web of Science ®Google Scholar
• VOLKOW ND, FOWLER JS, GATELY SJ et al.: PET evalua-tion of the dopamine system of the human brain. J. Nu-clear Med. (1996) 37:1242–1256.
   PubMed Web of Science ®Google Scholar
• RITZ MC, LAMB RJ, GOLDBERG SR, KUHAR MJ: Cocaine re-ceptors on dopamine transporters are related to self-administration of cocaine. Science (1987) 237:1219–1223.
   PubMed Web of Science ®Google Scholar
• WILSON MC, SCHUSTER CR: The effects of chlorpromaz-ine on psychomotor stimulant self administration in the rhesus monkey. Psychopharmacology (1972) 26:115–126.
   PubMedGoogle Scholar
• BERGMAN J, KAMIEN JB, SPEALMAN RD: Antagonism of cocaine self-administration by selective dopamine Di and Dy antagonists. Behav. Pharmacol (1990) 1:355–363.
   PubMedGoogle Scholar
• GLOWA JR, WOJNICKI FHE: Effects of drugs on food- and cocaine-maintained responding. III: dopaminergic an-tagonists. Psychopharmacology (1996) 123:34–41.
   PubMedGoogle Scholar
• WOOLVERTON WL: Effects of a Di and a D2 dopamineantagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem. Be-hay. (1986) 24:531–535.
   PubMed Web of Science ®Google Scholar
• WOOLVERTON WL, VIRUS RM: The effects of a Di and a Dy dopamine antagonist on behavior maintained by co-caine or food. Pharmacol Biochem. Behav. (1989) 32:691–697.
   PubMed Web of Science ®Google Scholar
• CAINE SB, KOOB GF: Effects of dopamine Di and Dy an-tagonists on cocaine self-administration under differ-ent schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. (1994) 270:209–218.
   PubMed Web of Science ®Google Scholar
• GLOWA JR, WOJNICKI FHE, MATECKA D et al: Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp. Clin. Psychopharmacol. (1995) 3:219-231. Showed a selective effect of the DA reuptake inhibitor, GBR12909, on cocaine-reinforced behaviour.
   Google Scholar
• GLOWA JR, WOJNICKI FHE, MATECKA D, RICE KC, ROTH-MAN RB: Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Compari-sons with other drugs and repeated administration. Exp. Clin. Psychopharmacol. (1995) 3:232–239.
   Google Scholar
• SKJOLDAGER P, WINGER G, WOODS JH: Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend. (1993) 33:31–39.
   PubMedGoogle Scholar
• CAINE SB, KOOB GF: Pretreatment with the dopamine agonist 7-011-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. (1995) 6:333–347.
   PubMed Web of Science ®Google Scholar
• GLOWA JR, FANTEGROSSI WE, LEWIS DB et al.: Sustained decreases in cocaine-maintained responding in rhesus monkeys with 142- [bis (fluorophe nyl) methoxy] ethyl]-4-(3-hydroxy-3-phenylpropy0 piperazinyl de-canoate, a long-acting ester derivative of GBR 12909. J. Med. Chem. (1996) 39:4689-4691. Showed that by formulating GBR 12909 as a decanoate, se-lective decreases in cocaine-reinforced behaviour could be obtained for thirty days with a single injection.
   Google Scholar
• SELF DW, BARNHART WJ, LEHMAN DA, NESTLER EJ: Op- posite modulation of cocaine-seeking behavior by Di-and D2-like dopamine receptor agonists. Science (1996) 271:1586–1588.
   PubMed Web of Science ®Google Scholar
• PROTAIS P, COSTENTIN J, SCHWARTZ JC: Climbing be-havior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psy-chopharmacology (1976) 50:1–6.
   PubMed Web of Science ®Google Scholar
• KLEVEN MS, WOOLVERTON WL: Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend. (1993) 31:149–158.
   PubMed Web of Science ®Google Scholar
• PELTIER R, SCHENK S: Effects of serotonergic manipula-tions on cocaine self-administration in rats. Psycho-pharmacology (1993) 110:390–394.
   PubMedGoogle Scholar
• TELLA SR: Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol. Biochem. Behav. (1995) 51:687–692.
   PubMedGoogle Scholar
• CAPPENDIJK SL, DZOLJIC MR: Inhibitory effects of ibo-gaine on cocaine self-administration in rats. Eur. J. Pharmacol. (1993) 241:261–265.
   PubMed Web of Science ®Google Scholar
• GLICK SD, KUEHNE ME, RAUCCI J et al.: Effects of iboga al-kaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to ef-fects on dopamine release in nucleus accumbens and striatum. Brain Res. (1994) 657:14–22.
   PubMed Web of Science ®Google Scholar
• DWORKIN SI, GLEESON S, MELONI D, KOVES TR, MARTINTJ: Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats. Psycho-pharmacology (1995) 117:257–261.
   PubMed Web of Science ®Google Scholar
• DEECHER DC, TEITLER M, SODERLUND DM et al.: Mecha-nisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res. (1992) 571:242–247.
   PubMed Web of Science ®Google Scholar
• PEARL SM, HERRICK-DAVIS M, TEITLER M, GLICK SD: Radioligand binding study of nor-ibogaine, a likely me-tabolite of ibogaine. Brain Res. (1995) 675:342–344.
   PubMedGoogle Scholar
• SWEETNAM PJ, LANCASTER A, SNOWMAN A et al.: Recep-tor binding profiles suggest multiple mechanisms are responsible for ibogaine's putative anti-addictive activ-ity. Psychopharmacology (1995) 118:369–376.
   PubMed Web of Science ®Google Scholar
• GOLD LH, BALSTER RL: Effects of buspirone and gepi-rone on iv. cocaine self-administration in rhesus mon-keys. Psychopharmacology (1992) 108:289–294.
   Google Scholar
• WALSH SL, CUNNINGHAM KA: Serotonergic mecha-nisms involved in the discriminative stimulus, rein-forcing and subjective effects of cocaine. Psychopharmacology (1997/8). (In Press).
   Google Scholar
• LANE JD, PICKERING CL, HOOPER ML et al.: Failure of on-dansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. Drug Alcohol De-pend. (1992) 30:151–162.
   PubMedGoogle Scholar
• DEPOORTERE RY, LI DH, LANE JD, EMMETT-OGLESBY MW: Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol. Bio-chem. Behav. (1993) 45:539–548.
   Google Scholar
• LACOSTA S, ROBERTS DCS: MDL 72222, ketanserin, andmethylsergide pretreatments fail to alter the breaking points on a progressive ratio schedule reinforced by in-travenous cocaine. Pharmacol Biochem. Behav. (1993) 44:161–165.
   PubMedGoogle Scholar
• HOWELL LL, BYRD LD: Serotonergic modulation of thebehavioral effects of cocaine in the squirrel monkey. J. Pharmacol. Exp. Ther. (1995) 275:1551–1559.
   PubMed Web of Science ®Google Scholar
• PELTIER RL, EMMETT-OGLESBY MW, THOMAS WH, SCHENK S: Failure of ritanserin to block the discrimina-tive or reinforcing stimulus effects of cocaine. Pharma-col. Biochem. Behav. (1993) 48:473–478.
   Google Scholar
• HUMPHREY PPA, FENIUK W, PERREN MJ et al.: GR43175, aselective agonist for the 5-HTi-like receptor in dog iso-lated saphenous vein. Br. J. Pharmacol. (1988) 94:1123–1132.
   PubMed Web of Science ®Google Scholar
• HOYER D, ENGEL G, KALKMAN HO: Molecular pharma-cology of 5-HT1 and 5-11T2 recognition sites in rat and pi i brain membranes: radioligand binding studies with [H ]5-HT, [113]8-0H-DPAT, (-) [125Iliodocyanopindolol, rillmesulergine and riliketanserin. Eur. J. Pharmacol. (1985) 118:13
   PubMed Web of Science ®Google Scholar
• HEURING RE, PEROUTKA SJ: Characterization of a novel311-5-hydroxytryptamine binding site subtype in bo-vine brain membranes. J. Neurosci. (1987) 7:894–903.
   PubMed Web of Science ®Google Scholar
• PAZOS A, HOYER D, PALACIOS JM: Mesulergine, a selec-tive serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur. Pharmacol. (1984) 106:531–538
   PubMedGoogle Scholar
• DE VRY J, DONSELAAR I, VAN REE JM: Food deprivationand acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and ha-loperidol. J. Pharmacol. Exp. Ther. (1989) 251:735–740.
   PubMedGoogle Scholar
• MELLO NK, LUKAS SE, BREE MP, MENDELSON JH: Desi-pramine effects on cocaine self-administration by rhesus monkeys. Drug Akohol Depend. (1990) 26:103–116.
   PubMedGoogle Scholar
• MELLO NK, MENDELSON JH, BREE MP, LUKAS SE: Bupre-norphine suppresses cocaine self-administration by rhesus monkeys. Science (1989) 245:859–862.
   PubMedGoogle Scholar
• UKAI M, MORI E, KAMEYAMA T: Cocaine-like discrimina-tive stimulus properties of the delta-selective opioid re-ceptor agonist [D-PEN2, L-PEN5] enkephalin, in the rat. Eur. Pharmacol. (1993) 231:143–144.
   PubMedGoogle Scholar
• REID LD, GLICK SD, MENKENS KA et al: Cocaine self-administration and naltrindole, a delta-selective opioid antagonist. NeuroReport (1995) 6:1409–1412.
   PubMed Web of Science ®Google Scholar
• REID LD, HUBBELL CL, GLACCUM MB et al.: Naltrindole,an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation. Life ScL (1993) 52:PL67–71.
   PubMedGoogle Scholar
• NEGUS SS, MELLO NK, PORTOGHESE PS, LUKAS SE, MEN-DELSON JH: Role of delta opioid receptors in the rein-forcing and discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. (1995) 273:1245–1256.
   PubMedGoogle Scholar
• DE VRIES TJ, BABOVIC-VUKSANOVIC D, ELMER G, SHIP-PENDERG TS: Lack of involvement of delta-opioid re-ceptors in mediating the rewarding effects of cocaine. Psychopharmacology (1995) 120:442–448.
   PubMed Web of Science ®Google Scholar
• GOEDERS NE, MCNULTY MA, GUERIN GF: Effects of al-prazolam on intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. (1993) 44:471–474.
   PubMedGoogle Scholar
• GOEDERS NE: A neuroendocrine role in cocaine rein-forcement. Psychoneuroendocrinology (1997) 22:237–259.
   PubMedGoogle Scholar
• GOEDERS NE, MCNULTY MA, MIRKIS S, MCALLLISTER KH:Chlordiazepoxide alters intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. (1989) 33:859–866.
   PubMedGoogle Scholar
• ROBERTS DCS, ANDREWS MM, VICKERS GJ: Baclofen at-tenuates the reinforcing effects of cocaine in rats. Neu-ropsychopharmacology (1996) 15:417–423.
   PubMed Web of Science ®Google Scholar
• HALIKAS JA, CROSBY RD, PEARSON VL, GRAVES NM: Arandomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clin. Pharmacol Ther. (1997) 62:89–105.
   PubMed Web of Science ®Google Scholar
• CORNISH JW, MAANY I, FUDALA P et al.: Carbamazepinetreatment of cocaine dependence. Drug Alcohol Depend. (1995) 38:221–227.
   PubMed Web of Science ®Google Scholar
• KRANZLER IR, BAUER LO, HERSH D, KLINGHOFFER V: Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. Drug Alcohol Depend. (1995) 38:203–211.
   PubMed Web of Science ®Google Scholar
• MONTOYA ID, LEVIN FR, FUDALA PJ, GORELICK DS: Double-blind comparison of carbamazepine and pla-cebo for treatment of cocaine dependence. Drug Alcohol Depend. (1995) 38:213–219.
   PubMed Web of Science ®Google Scholar
• HATSUKAMI D, KEENAN R, HALIKAS J, PENTEL PR, BRAUER LH: Effects of carbamazepine on acute re-sponses to smoked cocaine-base in human cocaine us-ers. Psychopharmacology (1991) 104:112–124.
   Google Scholar
• PULVIRENTI L, KOOB G: Lisurside reduces intravenous cocaine self-administration in rats. Pharmacol Biochem. Behav. (1991) 47:819–822.
   Google Scholar
• RITZ MC, GEORGE FR: Cocaine toxicity: concurrent in-fluence of dopaminergic, muscarinic and sigma recep-tors in mediating cocaine-induced lethality. Psychopharmacology (1997) 129:311–321.
   PubMed Web of Science ®Google Scholar
• AKIYAMA K, KANZAKI A, TSUCHIDA K, UJIKE H: Methamphetamine-induced behavioural sensitisation and its implications for relapse of schizophrenia. Schizophrenia Res. (1996) 12:251–257.
   Google Scholar
• WOLFE SA, DE SOUZA EB: Sigma and phencyclidine re-ceptors in the brain-endocrine-immune axis. NIDA Res. Monograph (1996) 133:95–123.
   Google Scholar
• WEBER E, SONDERS M, QUARUM M et al.: 1,3-Di(245-113Itolyflguanidine: a selective ligand that la-bels a-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. ScL USA (1986) 83:8784–8788.
   PubMed Web of Science ®Google Scholar
• NESTLER EJ, CARLEZON WA, BOUNDY VA et al.: Sensitiza-tion to morphine induced by viral-mediated gene trans-fer. Science 277:812–814.
   Google Scholar